L3VLUP
ProSign in

IMNM in the 13F filings

Immunome Inc · CUSIP 45257U108

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2025
the date the book describes
Filed
14 Nov 2025
latest of these filings; the earliest 14 Nov 2025
Managers listing it
2
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q2 2025 and Q3 2025; 2 listed it in both
Shares listed
6,099,233
combined, among listed positions
Reported value
$71m
combined, at the quarter end

Among the 95 comparable managers: 1 buyer (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares was -245,233.

Managers listing IMNM in Q3 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

2 of 2 holders

ActionFiling
Point72 Asset Management LP4,824,504$56m0.09%Added+138,70114 Nov 2025 (the filing on sec.gov)
Woodline Partners LP1,274,729$15m0.07%Trimmed-383,93414 Nov 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2025 to Q3 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q3 2024 to 1 in Q2 2026

Tracked managers listing it, at least.

0246Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
IMNM by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20231$9.9m10
Q1 20245$126m50
Q2 20243$70m22
Q3 20243$86m21
Q4 20242$47m11
Q1 20252$41m20
Q2 20252$59m20
Q3 20252$71m11
Q4 20253$202m145
Q1 20261$34m129
Q2 20261$21m813

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

IMNM and LLY →IMNM and JNJ →IMNM and VRTX →Choose a stock to compare with IMNM →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own IMNM, latest filings →Back to the 13F Explorer →